In stock · depth page
Retatrutide — COA and lot considerations (RUO)
Triple GIP / GLP-1 / glucagon receptor agonist · LY3437943
Retatrutide 10 / 20 / 30 mg · COA note
For laboratory research use only. Not for human or veterinary use, consumption, compounding into a medicine, or injection. Not authorized by Health Canada. Literature on this page is scientific context only. This page is not a licensed drug, a wellness protocol, or a dosing guide.
Match the COA to the sealed vial before the material is released to the bench. This is a process note for research-use-only material, not a potency claim.
What to match before bench release
Pass criteria: the COA header names retatrutide or LY3437943 and matches the purchase order; CAS 2381089-83-2 when the COA lists a registry number; strength 10, 20, or 30 mg matches the vial label; the COA lot equals the sealed vial lot; HPLC area percent is reported for the main peak under a stated method; observed mass or m/z is consistent with the expected peptide; the analysis date is recorded against ship and receipt; the storage statement aligns with the laboratory SOP and the COA.
Photograph or log the vial label (name, milligrams, lot). Archive the lot-matched COA with the invoice number. Quarantine the vial if lot, purity, or mass data disagree with the request record.
Method papers (Carneiro et al. on LC-HRMS; Streuli et al. on HPLC/FPLC transferability) are context for how identity and chromatography are discussed. They are not a substitute for the lot COA. An HPLC area-percent figure is an analytical attribute under the stated method. Do not convert it into a human-use claim.
Identity
Form
Lyophilized powder, sealed vial
Strength
10 mg, 20 mg, 30 mg lyophilized vials
Purity
HPLC area percent on the lot COA
CAS
- Retatrutide: 2381089-83-2
PubMed
Selected literature
- PMID 42745421 (2026) Carneiro et al., Rapid Communications in Mass Spectrometry — LC-HRMS detection / excretion profile of retatrutide (analytical context)
- PMID 41667417 (2026) Streuli et al., Journal of Peptide Science — HPLC/FPLC analysis transferability notes for peptide purification / analysis
Literature is scientific context only. A paper does not make a research vial into a licensed medicine.
Bench reconstitution
Identity and purity checks come before reconstitution. Dissolve the cake in bacteriostatic water only after the lot, HPLC area percent, and mass-spec identity agree with the receiving record.
Diluent page: bacteriostatic water.
Storage
Keep the lyophilized vial at 2–8 °C, protected from light and moisture, until the bench protocol calls for it. After reconstitution, hold at 2–8 °C; use within the sterility window your laboratory controls allow. Do not freeze–thaw repeatedly. Record open date and concentration in the notebook. Confirm the lot COA before you adopt a hold time.
Certificate of analysis
Every product has a View COA button. Where the lot certificate of analysis (identity and HPLC purity) is posted, it opens the certificate with a PDF download. Where it is not posted yet, the same button sends a request by email to request@pharmapeptidesrx.com, or you can write that address with the SKU. This page is not a COA.
Lab FAQ
Is an HPLC area-percent figure a clinical-grade claim?
No. It is an analytical attribute under the stated method for research-use-only material. Write request@pharmapeptidesrx.com and ask for the lot-matched COA on the named strength. This page does not publish prices or banking details. Invoices go out from request@ only.
In this library
In stock · list price
Request from the catalog
Every vial on the catalog shows its CAD list price. Add it to your request and we email the invoice. Labs pay by Interac e-Transfer. No card checkout.